; (II) the size or density of the mosquito population; or (III) the severity of the mosquito-borne disease, such that expected serious adverse health outcomes for the human population justify the waiver. ; and (D) by amending paragraph (6) to read as follows: (6) Number of grants A political subdivision or a consortium of political subdivisions may not receive more than one grant under paragraph (1). ; and (3) in subsection (f)— (A) in paragraph (1), by striking $100,000,000 for fiscal year 2003, and such sums as may be necessary for each of fiscal years 2004 through 2007 and inserting $130,000,000 for each of fiscal years 2017 through 2022 ; (B) in paragraph (2), by striking the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 and inserting other medical and public health preparedness and response laws ; and (C) in paragraph (3)— (i) in the heading, by striking 2004 and inserting 2018 ; and (ii) by striking 2004 and inserting 2018 . 3. Epidemiology-laboratory capacity grants Section 2821 of the Public Health Service Act ( 42 U.S.C. 300hh–31 ) is amended— (1) in subsection (a)(1), by inserting , including mosquito and other vector-borne diseases, after infectious diseases ; and (2) in subsection (b), by striking 2010 through 2013 and inserting 2017 through 2022 . 4. GAO study (a) Study The Comptroller General of the United States shall conduct a study on the state of surveillance and control of mosquito-borne infectious diseases in the United States and territories, including the state of preparedness for conducting such surveillance and control. The study shall include— (1) a description of the infrastructure and programs for mosquito control in the United States, including— (A) how such infrastructure and programs are organized and implemented at the Federal, State and local levels, including with respect to departments and agencies of the States, and local organizations (including special districts) involved in such control programs